Project Texas
Project Texas is a global, multi-line medical device company dedicated to minimally-invasive diagnostic, therapeutic and clinical procedures. During the launch of their new drug-eluting stent system the Company was presented with several unique challenges and opportunities vis-a-vis the strategic direction of related business units. Healthios stepped in to work with the leadership of the Company's endoscopy business unit to define, position, and articulate a 5-year growth strategy. This strategy included refined assumptions on industry growth, new products, pricing, market share, partnerships, and acquisitions. Healthios presented this strategy to a committee of Board of Directors in September 2003.
